Form 8-K - Current report:
SEC Accession No. 0001193125-25-073396
Filing Date
2025-04-04
Accepted
2025-04-04 16:05:14
Documents
14
Period of Report
2025-04-03
Items
Item 1.03: Bankruptcy or Receivership
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d916691d8k.htm   iXBRL 8-K 34269
2 EX-99.1 d916691dex991.htm EX-99.1 255050
  Complete submission text file 0001193125-25-073396.txt   467240

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grtsq-20250403.xsd EX-101.SCH 2513
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grtsq-20250403_lab.xml EX-101.LAB 17202
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grtsq-20250403_pre.xml EX-101.PRE 10789
17 EXTRACTED XBRL INSTANCE DOCUMENT d916691d8k_htm.xml XML 3637
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 25813949
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)